President Trump hasn’t talked much about Greenland in recent months. That doesn’t mean he has forgotten about it. His recent declaration that Medicare and Medicaid will soon pay for weight loss drugs such as Zepbound and Wegovy could be the key that unlocks Trump’s Greenland ambitions.
That’s because Denmark, which controls Greenland, is home to Novo Nordisk, the company that makes Ozempic and Wegovy. Trump’s deal is estimated to allow millions of Americans to access these drugs for weight loss for a mere $50 monthly co-pay, much less than the $499 a month that people currently pay if their insurance plan does not cover these medications.
Comments